Pulmonary Hypertension: Far from a Rare Disease—a Journey from Diagnosis to Treatment

A special issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425). This special issue belongs to the section "Acquired Cardiovascular Disease".

Deadline for manuscript submissions: 28 February 2026 | Viewed by 23

Special Issue Editors


E-Mail Website
Guest Editor
Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico 155, 00161 Rome, Italy
Interests: pulmonary arterial hypertension; heart failure

E-Mail Website
Guest Editor
Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico 155, 00161 Rome, Italy
Interests: pulmonary arterial hypertension; heart failure
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor Assistant
Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico 155, 00161 Rome, Italy
Interests: pulmonary arterial hypertension; heart failure; arrhythmias

Special Issue Information

Dear Colleagues,

Pulmonary hypertension (PH) is a complex and progressive condition characterized by elevated blood pressure in the pulmonary arteries, leading to significant morbidity and mortality. In recent years, there has been a growing interest in this disease, which requires a precise and accurate diagnostic workup. Avoiding misdiagnosis is essential to avoid prescribing inappropriate and dangerous treatments.

This Special Issue aims at providing a comprehensive overview of the latest advancements in the understanding, diagnosis, and treatment of pulmonary hypertension.

We would like to address different forms of PH, from the most frequent, such as PH associated with left heart disease, to the rarest, such as group 1 PH (pulmonary arterial hypertension). We invite contributions that explore the pathophysiological mechanisms underlying PH, including molecular and cellular pathways, genetic factors, and environmental influences. Manuscripts focusing on innovative diagnostic techniques, such as advanced imaging modalities and biomarker identification, are also welcome. Additionally, we seek papers that address the latest therapeutic strategies, including pharmacological interventions, surgical approaches, and emerging treatments aimed at improving patient outcomes.

This Special Issue will serve as a valuable resource for researchers, clinicians, and healthcare professionals involved in the management of pulmonary hypertension, offering insights into the current state of the field and future directions for research and clinical practice.

Dr. Giovanna Manzi
Dr. Silvia Papa
Guest Editors

Dr. Tommaso Recchioni
Guest Editor Assistant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pulmonary hypertension
  • pathophysiology
  • diagnosis
  • treatment
  • molecular mechanisms
  • cellular pathways
  • genetic factors
  • environmental influences
  • advanced imaging
  • biomarkers

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop